Filter
292
Filtered Results: 292
Text search:
antibacterial
drugs
Featured
Recommendations
33
New Publications
75
Language
Document type
Studies & Reports
85
No document type
84
Guidelines
79
Manuals
12
Strategic & Response Plan
12
Fact sheets
10
Training Material
4
Situation Updates
3
Brochures
1
Infographics
1
Online Courses
1
Countries / Regions
India
17
Ethiopia
16
Kenya
12
South Africa
12
Western and Central Europe
7
Ghana
6
Nigeria
6
Nepal
4
Global
4
Africa
3
Tanzania
3
Argentina
3
Bangladesh
3
Uganda
3
Thailand
2
Lesotho
2
Malawi
2
Philippines
2
Eastern Europe and Central Asia
2
Russia
2
Zambia
2
Myanmar / Burma
2
North Macedonia
1
Tajikistan
1
Ukraine
1
Serbia
1
Sierra Leone
1
China
1
Rwanda
1
Kazakhstan
1
Syria
1
Kyrgyzstan
1
Burkina Faso
1
Uzbekistan
1
Peru
1
Zimbabwe
1
Mongolia
1
Mozambique
1
Armenia
1
USA
1
Asia
1
Latin America and the Carribbean
1
Jordan
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
Bolivia
1
Vietnam
1
Eastern Europe
1
Papua New Guinea
1
Namibia
1
Sudan
1
Georgia
1
Libya
1
Bhutan
1
Botswana
1
Indonesia
1
Iraq
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
90
Clinical Guidelines
21
Women & Child Health
6
Key Resources
5
Pharmacy & Technologies
5
Public Health
4
Capacity Building
1
Toolboxes
AMR
122
Pharmacy
33
TB
22
NTDs
13
COVID-19
9
Rapid Response
6
Ebola & Marburg
6
Planetary Health
5
HIV
4
Caregiver
4
Specific Hazards
2
Cholera
2
Mental Health
1
Disability
1
Health Financing Toolbox
1
NCDs
1
Conflict
1
Global Health Education
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res...
Here you can find online courses on drug development, Pharmacology of Antibacterial Agents, pharmaceutical devices, etc.
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
WHO CIA list categorizes all antimicrobials used in human medicine into 3 groups based on their importance to human medicine. The current scope is limited to antibacterial drugs of which most are also used in veterinary medicine. The list assists in man...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community phar...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Fourth edition
Fourth edition
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
Second Edition, 2012
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development ...
